Kymera Therapeutics Employee Directory
Biotechnology ResearchMassachusetts, United States201-500 Employees
Kymera Therapeutics is a clinical-stage biotechnology company based in Watertown, Massachusetts, founded in 2016. It pursues targeted protein degradation as a therapeutic strategy to address disease targets and pathways that conventional medicines cannot effectively treat. The company has advanced its first degrader into clinical development for immunological diseases and aims to deliver oral small molecule degraders to broaden therapeutic options. Kymera positions itself in the biotechnology research industry around a targeted protein degradation modality with the aim of broadening treatment options for immunological diseases. In June 2026, the company announced the appointment of Penny Carlson as Senior Vice President, Development Operations.